Lehe Yang

430 total citations
21 papers, 305 citations indexed

About

Lehe Yang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Lehe Yang has authored 21 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Lehe Yang's work include RNA modifications and cancer (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Fibroblast Growth Factor Research (3 papers). Lehe Yang is often cited by papers focused on RNA modifications and cancer (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Fibroblast Growth Factor Research (3 papers). Lehe Yang collaborates with scholars based in China and United States. Lehe Yang's co-authors include Xiaoying Huang, Chengguang Zhao, Liangxing Wang, Dandan Zheng, Feng Zhou, Xiaokun Li, Dandan Wang, Xiaoying Huang, Chengguang Zhao and Dandan Wang and has published in prestigious journals such as PLoS ONE, Oncogene and Journal of Ethnopharmacology.

In The Last Decade

Lehe Yang

19 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lehe Yang China 11 157 95 46 41 30 21 305
Yun‐Ru Liu Taiwan 11 167 1.1× 52 0.5× 67 1.5× 40 1.0× 37 1.2× 23 305
Lixin Yan China 10 197 1.3× 96 1.0× 30 0.7× 134 3.3× 25 0.8× 16 364
Xiaofang Jin China 10 126 0.8× 46 0.5× 26 0.6× 29 0.7× 22 0.7× 14 300
Zhaohu Xie China 7 196 1.2× 53 0.6× 21 0.5× 64 1.6× 16 0.5× 18 332
Shuyi Han China 10 161 1.0× 27 0.3× 42 0.9× 42 1.0× 34 1.1× 15 358
Xufeng Huang Hungary 12 160 1.0× 71 0.7× 109 2.4× 94 2.3× 29 1.0× 26 364
Changming Wang China 7 205 1.3× 146 1.5× 35 0.8× 44 1.1× 24 0.8× 10 396
Yasuyuki Shinozaki Japan 11 146 0.9× 91 1.0× 26 0.6× 15 0.4× 35 1.2× 22 359
Aude Pflieger Canada 7 167 1.1× 234 2.5× 30 0.7× 70 1.7× 23 0.8× 7 365
Shaoyan Gao China 10 125 0.8× 204 2.1× 41 0.9× 32 0.8× 25 0.8× 18 364

Countries citing papers authored by Lehe Yang

Since Specialization
Citations

This map shows the geographic impact of Lehe Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lehe Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lehe Yang more than expected).

Fields of papers citing papers by Lehe Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lehe Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lehe Yang. The network helps show where Lehe Yang may publish in the future.

Co-authorship network of co-authors of Lehe Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lehe Yang. A scholar is included among the top collaborators of Lehe Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lehe Yang. Lehe Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Xiao, et al.. (2025). Organizing pneumonia in ALK+ non-small cell lung cancer treated with ceritinib: a case report. Discover Oncology. 16(1). 1363–1363.
2.
Chen, Zhili, Yijia Wang, Haijian Cai, et al.. (2024). Parthenolide attenuates hypoxia-induced pulmonary hypertension through inhibiting STAT3 signaling. Phytomedicine. 134. 155976–155976. 3 indexed citations
3.
Yang, Jie, et al.. (2024). CDK4/6 inhibitors in lung cancer: current practice and future directions. European Respiratory Review. 33(171). 230145–230145. 19 indexed citations
4.
Li, Cong, et al.. (2024). Unveiling HOXB7 as a novel diagnostic and prognostic biomarker through pan-cancer computer screening. Computers in Biology and Medicine. 176. 108562–108562. 1 indexed citations
5.
Xu, Tingting, et al.. (2023). Stem cell therapy in pulmonary hypertension: current practice and future opportunities. European Respiratory Review. 32(169). 230112–230112. 8 indexed citations
6.
Ye, Huihui, Xiuchun Li, Jiajia Jin, et al.. (2023). Fibroblast Growth Factor 21 Relieves Lipopolysaccharide-Induced Acute Lung Injury by Suppressing JAK2/STAT3 Signaling Pathway. Inflammation. 47(1). 209–226. 11 indexed citations
7.
Zhao, Chengguang, et al.. (2023). The emerging role of the piRNA/PIWI complex in respiratory tract diseases. Respiratory Research. 24(1). 76–76. 9 indexed citations
8.
Yang, Lehe, Hongyan Qu, Yan-ting Gu, et al.. (2023). Gracillin relieves pulmonary fibrosis by suppressing the STAT3 axis. Journal of Ethnopharmacology. 316. 116704–116704. 8 indexed citations
9.
10.
11.
Cai, Haijian, et al.. (2022). Roles of Embryonic Lethal Abnormal Vision-Like RNA Binding Proteins in Cancer and Beyond. Frontiers in Cell and Developmental Biology. 10. 847761–847761. 9 indexed citations
12.
Sun, Junwei, Xiuchun Li, Jingyin Li, et al.. (2022). FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ. Journal of Cellular and Molecular Medicine. 26(4). 1034–1049. 15 indexed citations
13.
Zheng, Dandan, et al.. (2021). Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases. Frontiers in Cell and Developmental Biology. 9. 698751–698751. 25 indexed citations
14.
Yang, Lehe, Feng Zhou, Dandan Zheng, et al.. (2021). FGF/FGFR signaling: From lung development to respiratory diseases. Cytokine & Growth Factor Reviews. 62. 94–104. 70 indexed citations
15.
Zhao, Chengguang, Lehe Yang, Feng Zhou, et al.. (2020). Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells. Oncogene. 39(20). 3997–4013. 28 indexed citations
16.
Yang, Lehe, Deguang Mu, Yaqing Li, et al.. (2019). <p>Resveratrol downregulates TNF-α-induced monocyte chemoattractant protein-1 in primary rat pulmonary artery endothelial cells by P38 mitogen-activated protein kinase signaling</p>. Drug Design Development and Therapy. Volume 13. 1843–1853. 17 indexed citations
17.
Chen, Chan, Chun Chen, Zhiyi Wang, et al.. (2012). Puerarin Induces Mitochondria-Dependent Apoptosis in Hypoxic Human Pulmonary Arterial Smooth Muscle Cells. PLoS ONE. 7(3). e34181–e34181. 31 indexed citations
18.
Yang, Lehe, et al.. (2011). Transplantation of Schwann Cells Differentiated from Adipose-Derived Stem Cells Modifies Reactive Gliosis after Contusion Brain Injury in Rats. Journal of International Medical Research. 39(4). 1344–1357. 10 indexed citations
19.
Wang, Liangxing, et al.. (2010). Prevalence of virulence genes and biofilm formation among Staphylococcus aureus clinical isolates associated with lower respiratory infection. African Journal of Microbiology Research. 4(23). 2566–2569. 24 indexed citations
20.
Wilson, Christine, et al.. (1987). Methemoglobinemia Following Metoclopramide Therapy in an infant. Journal of Pediatric Gastroenterology and Nutrition. 6(4). 642–642. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun‐Ru Liu Breakdown of academic impact, for papers by Lixin Yan Breakdown of academic impact, for papers by Xiaofang Jin Breakdown of academic impact, for papers by Zhaohu Xie Breakdown of academic impact, for papers by Shuyi Han Breakdown of academic impact, for papers by Xufeng Huang Breakdown of academic impact, for papers by Changming Wang Breakdown of academic impact, for papers by Yasuyuki Shinozaki Breakdown of academic impact, for papers by Aude Pflieger Breakdown of academic impact, for papers by Shaoyan Gao
Rankless by CCL
2026